Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APYX NASDAQ:IRMD NASDAQ:PLSE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPYXApyx Medical$4.30$4.07$1.59▼$5.08$180.22M1.37152,317 shs68,999 shsIRMDiRadimed$100.97$91.05$55.11▼$107.90$1.29B0.9135,853 shs130,063 shsPLSEPulse Biosciences$29.20$24.80$12.56▼$31.00$2.02B1.65353,450 shs182,735 shsDon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPYXApyx Medical0.00%-4.44%+13.46%+16.85%+100.00%IRMDiRadimed0.00%+7.46%+10.81%+4.93%+64.07%PLSEPulse Biosciences0.00%+2.64%+16.85%+26.96%+90.60%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPYXApyx Medical$4.30$4.07$1.59▼$5.08$180.22M1.37152,317 shs68,999 shsIRMDiRadimed$100.97$91.05$55.11▼$107.90$1.29B0.9135,853 shs130,063 shsPLSEPulse Biosciences$29.20$24.80$12.56▼$31.00$2.02B1.65353,450 shs182,735 shsDon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPYXApyx Medical0.00%-4.44%+13.46%+16.85%+100.00%IRMDiRadimed0.00%+7.46%+10.81%+4.93%+64.07%PLSEPulse Biosciences0.00%+2.64%+16.85%+26.96%+90.60%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPYXApyx Medical 2.67Moderate Buy$6.5051.16% UpsideIRMDiRadimed 3.00Buy$120.0018.85% UpsidePLSEPulse Biosciences 2.50Moderate Buy$30.675.02% UpsideCurrent Analyst Ratings BreakdownLatest IRMD, PLSE, and APYX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/24/2026APYXApyx Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)6/4/2026PLSEPulse Biosciences Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$32.005/20/2026IRMDiRadimed Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B) ➝ Buy (B-)5/6/2026IRMDiRadimed Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeBuy (B-) ➝ Buy (B)4/21/2026PLSEPulse Biosciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)(Data available from 7/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPYXApyx Medical$52.84M3.41N/AN/A$0.39 per share11.03IRMDiRadimed$83.81M15.40$1.86 per share54.32$7.44 per share13.57PLSEPulse Biosciences$350K5,774.09N/AN/A$1.19 per share24.54Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPYXApyx Medical-$11.21M-$0.22N/AN/AN/A-16.40%-88.47%-14.94%8/6/2026 (Estimated)IRMDiRadimed$22.48M$1.8355.18N/AN/A27.36%24.48%21.25%7/30/2026 (Estimated)PLSEPulse Biosciences-$72.78M-$1.10N/AN/AN/AN/A-86.67%-73.61%8/11/2026 (Estimated)Latest IRMD, PLSE, and APYX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2026Q2 2026IRMDiRadimed$0.44N/AN/AN/A$20.35 millionN/A5/7/2026Q1 2026APYXApyx Medical-$0.11-$0.05+$0.06-$0.05$10.53 million$12.49 million5/4/2026Q1 2026PLSEPulse Biosciences-$0.32-$0.27+$0.05-$0.27$0.25 million$0.40 million5/1/2026Q1 2026IRMDiRadimed$0.46$0.49+$0.03$0.45$21.32 million$21.98 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAPYXApyx MedicalN/AN/AN/AN/AN/AIRMDiRadimed$0.800.79%N/A43.72%1 YearsPLSEPulse BiosciencesN/AN/AN/AN/AN/ALatest IRMD, PLSE, and APYX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/30/2026IRMDiRadimedquarterly$0.200.93%5/15/20265/15/20265/29/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPYXApyx Medical2.685.804.79IRMDiRadimedN/A7.136.15PLSEPulse BiosciencesN/A7.267.24Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPYXApyx Medical55.33%IRMDiRadimed92.34%PLSEPulse Biosciences76.95%Insider OwnershipCompanyInsider OwnershipAPYXApyx Medical15.20%IRMDiRadimed34.60%PLSEPulse Biosciences74.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPYXApyx Medical27041.91 million35.54 millionOptionableIRMDiRadimed11012.78 million8.36 millionOptionablePLSEPulse Biosciences14069.21 million18.00 millionOptionableIRMD, PLSE, and APYX HeadlinesRecent News About These CompaniesWhat Do Pulse Biosciences’ New Equity Awards Reveal About Executive Compensation Trends?June 15, 2026 | kalkinemedia.comKWhat Could New Equity Awards Signal for Pulse Biosciences’ Ongoing Growth Efforts?June 15, 2026 | kalkinemedia.comKPulse Biosciences Shareholders Approve Board and Auditor SlateJune 12, 2026 | tipranks.comPulse Biosciences, Inc. (PLSE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptJune 10, 2026 | seekingalpha.comPulse Biosciences Updates 2026 Cardiac Ablation StrategyJune 10, 2026 | theglobeandmail.comPulse Bio to redeem remaining common stock warrantsJune 10, 2026 | seekingalpha.comDid New Analyst Coverage and Insider Buying Just Shift Pulse Biosciences' (PLSE) Investment Narrative?June 9, 2026 | finance.yahoo.comPulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026May 27, 2026 | businesswire.comHere's Why Pulse Biosciences, Inc (PLSE) is a Great Momentum Stock to BuyMay 26, 2026 | zacks.comWhy Pulse Biosciences, Inc.’s (PLSE) Stock Is Down 6.55%May 16, 2026 | aaii.comAPulse Biosciences, Inc. (PLSE) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks TranscriptMay 13, 2026 | seekingalpha.comPulse Biosciences, Inc. (PLSE) Presents at Bank of America Global Healthcare Conference 2026 - SlideshowMay 13, 2026 | seekingalpha.comPulse Biosciences (NASDAQ:PLSE) CEO Acquires $295,350.00 in StockMay 12, 2026 | insidertrades.comPulse Biosciences Authorizes Insider Purchases Under Equity ProgramMay 11, 2026 | theglobeandmail.comIs Pulse Biosciences (PLSE) Quietly Redefining Its Core Identity Around Atrial Fibrillation?May 11, 2026 | finance.yahoo.comPLSE Q1 2026 Earnings TranscriptMay 8, 2026 | finance.yahoo.comPulse Biosciences to Present at the BofA Securities 2026 Healthcare ConferenceMay 8, 2026 | finance.yahoo.comPulse Biosciences, Inc. (PLSE) Q1 2026 Earnings Call TranscriptMay 8, 2026 | seekingalpha.comPulse Biosciences (PLSE) Upgraded to Buy: What Does It Mean for the Stock?May 7, 2026 | zacks.comPulse Biosciences Reports Business Updates and First Quarter 2026 Financial ResultsMay 4, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeIRMD, PLSE, and APYX Company DescriptionsApyx Medical NASDAQ:APYX$4.30 0.00 (0.00%) Closing price 07/2/2026 04:00 PM EasternExtended Trading$4.30 0.00 (-0.12%) As of 07/2/2026 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.iRadimed NASDAQ:IRMD$100.97 0.00 (0.00%) Closing price 07/2/2026 04:00 PM EasternExtended Trading$100.88 -0.09 (-0.09%) As of 07/2/2026 04:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.Pulse Biosciences NASDAQ:PLSE$29.20 0.00 (0.00%) Closing price 07/2/2026 04:00 PM EasternExtended Trading$29.02 -0.18 (-0.63%) As of 07/2/2026 06:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/29 - 07/03 Why Flywire and Airbnb Could Be Quiet Winners of a Ceasefire Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst SanDisk’s Volatility May Be Telling Bulls What They Want to Hear Broadcom and OpenAI Unveil Jalapeño: An Early Step to Massive AI Growth Potential Why the Comcast Spin-Off Won't Fix What's Actually Broken Shorting the Grid: Bloom Energy’s $25B AI Power Play Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
